Comprehensively, in this work, we provide evidence for ATGL downregulation in both human and murine HCC and we describe the mechanisms whereby this lipase contributes to metabolic rewiring through p53 stabilization and the identification of a previously uncovered ATGL/PPAR-α/p300 axis. This evidence concerns the gene TP53 and hepatocellular carcinoma.